MCVAX Performance — Transamerica Mid Cap Value Opportunities, Class A
Data updated: 2026-09-28
MCVAX returned +8.92% year to date and +14.17% over one year to Jul 2026. Annualised returns are +9.15% over 3 years and +6.73% over 5 years. The fund trailed its US Mid-Cap Value category average: $100 invested three years ago grew to $130, against $145 for the category, and to $114 over one year, against $120. Volatility over the past three years was 12.48% a year. In the 12 months to Jul 2026 the fund lost a net $180.5M, and assets reached $775.46M.
MCVAX Growth of $100
What $100 invested in Transamerica Mid Cap Value Opportunities grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Value category average over the same months.
| Period | MCVAX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $114 | $120 |
| 3 years (Aug 2023 – Jul 2026) | $130 | $145 |
| 5 years (Aug 2021 – Jul 2026) | $138 | $156 |
| Since data start (Aug 2019 – Jul 2026) | $178 | $212 |
MCVAX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +8.92% |
| 1 year | +14.17% |
| 3 years (annualised) | +9.15% |
| 5 years (annualised) | +6.73% |
MCVAX Annual Returns
Calendar-year total returns of Transamerica Mid Cap Value Opportunities, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +8.92% |
| 2025 | +9.48% |
| 2024 | +6.86% |
| 2023 | +9.97% |
| 2022 | −6.98% |
| 2021 | +25.34% |
| 2020 | +3.84% |
| 2019 (Aug–Dec) | +4.83% |
MCVAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.0% | +2.2% | −6.3% | +4.2% | +0.5% | −1.1% | +5.5% | — | — | — | — | — |
| 2025 | +3.3% | −0.2% | −1.0% | −2.6% | +2.0% | +2.8% | +0.2% | +4.9% | −1.0% | −2.2% | +2.5% | +0.7% |
| 2024 | −0.1% | +2.0% | +4.6% | −4.9% | +2.0% | −2.8% | +7.8% | +0.8% | −0.5% | −1.4% | +6.4% | −6.2% |
| 2023 | +8.0% | −4.1% | −2.8% | +1.1% | −5.1% | +7.2% | +4.1% | −1.6% | −3.8% | −3.5% | +5.7% | +5.8% |
| 2022 | −1.2% | −0.3% | +3.4% | −4.4% | +5.6% | −10.2% | +6.3% | −2.9% | −10.6% | +8.6% | +4.8% | −4.1% |
| 2021 | −0.5% | +5.9% | +6.2% | +5.1% | +2.6% | −2.1% | −0.2% | +2.5% | −2.9% | +3.3% | −3.2% | +6.7% |
| 2020 | −1.4% | −9.7% | −24.2% | +13.9% | +5.5% | +0.2% | +2.6% | +4.5% | −3.2% | +1.3% | +15.3% | +5.3% |
| 2019 | — | — | — | — | — | — | — | −4.4% | +5.1% | 0.0% | +1.6% | +2.7% |
MCVAX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 12.48%
- 3-year Sharpe ratio: 0.37 (vs 4.5% risk-free rate)
- Best month: +7.79% (Jul 2024)
- Worst month: −6.29% (Mar 2026)
MCVAX Fund Flows
Monthly money in and out of Transamerica Mid Cap Value Opportunities, from SEC Form N-PORT.
- 12-month net flow: −$180.5M
- 12-month gross sales (incl. reinvestments): $229.0M
- Sales ÷ redemptions: 0.56×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $9.3M | $21.2M | −$11.9M |
| Jun 2026 | $3.6M | $38.9M | −$35.4M |
| May 2026 | $5.0M | $27.5M | −$22.5M |
| Apr 2026 | $3.7M | $26.9M | −$23.2M |
| Mar 2026 | $8.0M | $26.0M | −$18.0M |
| Feb 2026 | $6.7M | $29.5M | −$22.8M |
| Jan 2026 | $21.4M | $32.2M | −$10.8M |
| Dec 2025 | $142.4M | $102.7M | $39.7M |
| Nov 2025 | $4.6M | $32.6M | −$28.0M |
| Oct 2025 | $11.3M | $23.8M | −$12.5M |
| Sep 2025 | $6.6M | $27.2M | −$20.6M |
| Aug 2025 | $6.5M | $21.0M | −$14.5M |
MCVAX Assets Under Management
Net assets of Transamerica Mid Cap Value Opportunities by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $775.46M |
| 2026-04-30 | $808.96M |
| 2026-01-31 | $873.88M |
| 2025-10-31 | $940.02M |
| 2025-07-31 | $970.38M |
| 2025-04-30 | $965.50M |
| 2025-01-31 | $1.10B |
| 2024-10-31 | $1.21B |
| 2024-07-31 | $1.29B |
| 2024-04-30 | $1.30B |
| 2024-01-31 | $1.37B |
| 2023-10-31 | $1.31B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.